1. Home
  2. RVMD vs OR Comparison

RVMD vs OR Comparison

Compare RVMD & OR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • OR
  • Stock Information
  • Founded
  • RVMD 2014
  • OR 2014
  • Country
  • RVMD United States
  • OR Canada
  • Employees
  • RVMD N/A
  • OR N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • OR Precious Metals
  • Sector
  • RVMD Health Care
  • OR Basic Materials
  • Exchange
  • RVMD Nasdaq
  • OR Nasdaq
  • Market Cap
  • RVMD 7.5B
  • OR 7.4B
  • IPO Year
  • RVMD 2020
  • OR N/A
  • Fundamental
  • Price
  • RVMD $47.66
  • OR $37.92
  • Analyst Decision
  • RVMD Strong Buy
  • OR Buy
  • Analyst Count
  • RVMD 15
  • OR 4
  • Target Price
  • RVMD $74.47
  • OR $31.75
  • AVG Volume (30 Days)
  • RVMD 2.3M
  • OR 1.4M
  • Earning Date
  • RVMD 11-05-2025
  • OR 11-05-2025
  • Dividend Yield
  • RVMD N/A
  • OR 0.49%
  • EPS Growth
  • RVMD N/A
  • OR N/A
  • EPS
  • RVMD N/A
  • OR 0.42
  • Revenue
  • RVMD N/A
  • OR $213,999,000.00
  • Revenue This Year
  • RVMD N/A
  • OR $80.79
  • Revenue Next Year
  • RVMD $454.11
  • OR $12.96
  • P/E Ratio
  • RVMD N/A
  • OR $97.23
  • Revenue Growth
  • RVMD N/A
  • OR 13.88
  • 52 Week Low
  • RVMD $29.17
  • OR $17.55
  • 52 Week High
  • RVMD $62.40
  • OR $42.25
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 65.02
  • OR 56.00
  • Support Level
  • RVMD $45.80
  • OR $38.73
  • Resistance Level
  • RVMD $49.50
  • OR $42.25
  • Average True Range (ATR)
  • RVMD 1.54
  • OR 1.37
  • MACD
  • RVMD 0.04
  • OR -0.16
  • Stochastic Oscillator
  • RVMD 72.95
  • OR 24.29

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About OR Osisko Gold Royalties Ltd

OR Royalties Inc, formerly Osisko Gold Royalties Ltd is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. Geographically, it generates majority of its income from North America and also generates some portions of income from South America, Australia, Africa and Europe.

Share on Social Networks: